Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-l-aspartyl chlorin e6)
- 1 July 1999
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 106 (7), 1384-1391
- https://doi.org/10.1016/s0161-6420(99)00729-0
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examplesAlbrecht von Graefes Archiv für Ophthalmologie, 1998
- Intravenous Infusion of Liposomal Benzoporphyrin Derivative for Photodynamic Therapy of Experimental Choroidal NeovascularizationArchives of Ophthalmology (1950), 1996
- Liposomal Benzoporphyrin Derivative Verteporfin Photodynamic TherapyOphthalmology, 1996
- Photodynamic Therapy of Experimental Choroidal Neovascularization Using Lipoprotein-Delivered BenzoporphyrinArchives of Ophthalmology (1950), 1995
- Retinal and choroidal vessel closure using phthalocyanine photodynamic therapyLasers in Surgery and Medicine, 1994
- Phthalocyanine photodynamic therapy: New strategy for closure of choroidal neovascularizationLasers in Surgery and Medicine, 1994
- In vitro photosensitization II. An electron microscopy study of cellular destruction with mono‐L‐aspartyl chlorin e6 and photofrin IILasers in Surgery and Medicine, 1989
- In vitro photosensitization I. Cellular uptake and subcellular localization of mono‐L‐aspartyl chlorin e6, chloro‐aluminum sulfonated phthalocyanine, and photofrin IILasers in Surgery and Medicine, 1989
- In Vitro Characterization of Monoaspartyl Chlorin e6 and Diaspartyl Chlorin e6 for Photodynamic TherapyJNCI Journal of the National Cancer Institute, 1988